Resistance training decreased abdominal adiposity in postmenopausal women.
Abdominal fat mass
Cardiovascular disease risks
Health
Postmenopausal
Resistance training
Journal
Maturitas
ISSN: 1873-4111
Titre abrégé: Maturitas
Pays: Ireland
ID NLM: 7807333
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
04
01
2023
revised:
31
05
2023
accepted:
19
06
2023
medline:
25
8
2023
pubmed:
9
7
2023
entrez:
8
7
2023
Statut:
ppublish
Résumé
To investigate if abdominal adipose tissue volumes and ratios change after a 15-week structured resistance training intervention in postmenopausal women with vasomotor symptoms (VMS). Sixty-five postmenopausal women with VMS and low physical activity were randomized to either three days/week supervised resistance training or unchanged physical activity for 15 weeks. Women underwent clinical anthropometric measurements and magnetic resonance imaging (MRI) at baseline and after 15 weeks. MRI was done using a Philips Ingenia 3.0 T MR scanner (Philips, Best, The Netherlands). The per protocol principle was used in the analysis of data. The absolute change from baseline to week 15 in visceral adipose tissue (VAT) volume and the relative ratio (VAT ratio) between VAT and total abdominal adipose tissue (TAAT), i.e. the sum of abdominal subcutaneous adipose tissue (ASAT) and VAT. There were no significant differences between the groups in characteristics, anthropometry or MRI measures at baseline. Women who were compliant with the intervention (i.e. participated in at least two of the three scheduled training sessions per week) had significantly different reduction over time in ASAT (p = 0.006), VAT (p = 0.002), TAAT (p = 0.003) and fat ratio (p < 0.001) compared with women in the control group. Implementation of a 15-week resistance training regimen in midlife may help women to counteract the abdominal fat redistribution associated with the menopausal transition. gov registered ID: NCT01987778.
Identifiants
pubmed: 37421844
pii: S0378-5122(23)00400-0
doi: 10.1016/j.maturitas.2023.107794
pii:
doi:
Banques de données
ClinicalTrials.gov
['NCT01987778']
Types de publication
Randomized Controlled Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
107794Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest Janne West and Magnus Borga are shareholders of AMRA Medical AB. No other competing interests exist among the authors.